NanoPalm NanoPalm is a DeepTech-Bio company revolutionizing in-vivo therapies for genetic diseases with an advanced Lipid Nanoparticle (LNP) manufacturing process designed by a proprietary AI platform, EnsaliX, to create stable LNPs that can self-target specific organs and cells without the downsides of current LNP-based therapies. Technology Developer  |